Antigen presentation and immune regulatory capacity of immature and mature-enriched antigen presenting (dendritic) cells derived from human bone marrow

Xiao, 2001, Bone marrow-derived dendritic cells from experimental allergic encephalomyelitis induce immune tolerance to EAE in Lewis rats, Clin Exp Immunol, 125, 300, 10.1046/j.1365-2249.2001.01573.x Adler, 1998, CD4+ T cell tolerance to parenchymal self-antigens requires presentation by bone marrow-derived antigen presenting cells, J Exp Med, 187, 1555, 10.1084/jem.187.10.1555 Finkelman, 1996, Dendritic cells can present antigen in vivo in a tolerogenic or immunogenic fashion, J Immunol, 157, 1406, 10.4049/jimmunol.157.4.1406 Dhodapkar, 2001, Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells, J Exp Med, 193, 233, 10.1084/jem.193.2.233 Steinman, 2000, The induction of tolerance by dendritic cells that have captured apoptotic cells, J Exp Med, 191, 411, 10.1084/jem.191.3.411 Jonuleit, 2000, Induction of interleukin 10-producing, nonproliferating CD4+ T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells, J Exp Med, 192, 1213, 10.1084/jem.192.9.1213 Mathew, 1997, Modulatory effects of human donor bone marrow cells on allogeneic cellular immune responses, Transplantation, 63, 686, 10.1097/00007890-199703150-00013 Mathew, 1998, Cellular immune responses of human cadaver donor bone marrow cells and their susceptibility to commonly used immunosuppressive drugs in transplantation, Transplantation, 65, 947, 10.1097/00007890-199804150-00015 Mathew, 2000, Donor bone marrow-derived chimeric cells present in renal transplant recipients infused with donor marrow. I. Potent regulators of recipient anti-donor immune responses, Transplantation, 70, 1675, 10.1097/00007890-200012270-00003 Jin, 2000, Bone marrow cells inhibit the generation of autologous EBV-specific CTL, Hum Immunol, 61, 538, 10.1016/S0198-8859(00)00120-8 Miller, 1999, The human bone marrow as an immunoregulatory organ, Transplantation, 68, 1079, 10.1097/00007890-199910270-00001 Jin, 2000, Bone marrow cells promote TH2 polarization and inhibit virus-specific CTL generation, Human Immunol, 61, 1233, 10.1016/S0198-8859(00)00206-8 Jin, 2002, Functional and phenotypic properties of peripheral T cells anergized by autologous CD3+ depleted bone marrow cells, Hum Immunol, 63, 567, 10.1016/S0198-8859(02)00402-0 Wesa, 2001, Regulation of T cell cytokine production by dendritic cells generated in vitro from hematopoietic progenitor cells, Cell Immunol, 208, 115, 10.1006/cimm.2001.1773 Banchereau, 1998, Dendritic cells and the control of immunity, Nature, 392, 245, 10.1038/32588 Kalinski, 1997, IL-12-deficient dendritic cells, generated in the presence prostaglandin E2, promote type 2 cytokine production in maturing human naı̈ve T helper cells, J Immunol, 159, 28, 10.4049/jimmunol.159.1.28 Tanaka, 2000, Human monocyte-derived dendritic cells induce naïve T cell differentiation into T helper cell type 2 (Th2) or Th1/Th2 effectors. Role of stimulator/responder ratio, J Exp Med, 192, 405, 10.1084/jem.192.3.405 Inaba, 1994, The tissue distribution of the B7-2 costimulator in mice, J Exp Med, 180, 1849, 10.1084/jem.180.5.1849 Sozzani, 1998, Differential regulation of chemokine receptors during dendritic cell maturation, J Immunol, 161, 1083, 10.4049/jimmunol.161.3.1083 Li, 2001, Bipartite regulation of different components of the MHC class I antigen-processing machinery during dendritic cell maturation, Int Immunol, 13, 1515, 10.1093/intimm/13.12.1515 Baker, 2001, Loss of direct and maintenance of indirect alloresponses in renal allograft recipients, J Immunol, 167, 7199, 10.4049/jimmunol.167.12.7199 Ciancio, 2002, Effect of living-related donor bone marrow infusion on chimerism and in vitro immunoregulatory activity in kidney transplant recipients, Transplantation, 74, 488, 10.1097/00007890-200208270-00010 Garcia-Morales, 1997, The effects of chimeric cells following donor bone marrow infusions as detected by PCR-flow assays in kidney transplant recipients, J Clin Invest, 99, 1118, 10.1172/JCI119240 Steinman, 2000, The induction of tolerance by dendritic cells that have captured apoptotic cells, J Exp Med, 191, 411, 10.1084/jem.191.3.411 Rodriguez, 1999, Selective transport of internalized antigens to the cytosol for MHC class I presentation in dendritic cells, Nat Cell Biol, 1, 362, 10.1038/14058 Rescigno, 1998, Bacteria-induced neo-biosynthesis, stabilization, and surface expression of functional class I molecules in mouse dendritic cells, Proc Natl Acad Sci USA, 95, 5229, 10.1073/pnas.95.9.5229 Rock, 1994, Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules, Cell, 78, 761, 10.1016/S0092-8674(94)90462-6 Chu-Ping, 1992, Identification, purification, and characterization of a protein activator (PA28) of the 20S proteasome (macropain), J Biol Chem, 267, 10515, 10.1016/S0021-9258(19)50047-3 Van Hall, 2000, Differential influence on cytotoxic T lymphocyte epitope presentation by controlled expression of either proteasome immunosubunits or PA28, J Exp Med, 192, 483, 10.1084/jem.192.4.483 Groettrup, 1996, A role for the proteasome regulator PA28alpha in antigen presentation, Nature, 381, 166, 10.1038/381166a0 Kleijmeer, 2001, Antigen loading of MHC class I molecules in the endocytic tract, Traffic, 2, 124, 10.1034/j.1600-0854.2001.020207.x Benichou, 1999, Contribution of direct and indirect T cell alloreactivity during allograft rejection in mice, J Immunol, 162, 352, 10.4049/jimmunol.162.1.352 Mathew, 2000, Involvement of multiple subpopulations of human bone marrow cells in the regulation of allogeneic cellular immune responses, Transplantation, 70, 1752, 10.1097/00007890-200012270-00015